1. Home
  2. PRAA vs VOR Comparison

PRAA vs VOR Comparison

Compare PRAA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PRA Group Inc.

PRAA

PRA Group Inc.

N/A

Current Price

$18.41

Market Cap

639.1M

Sector

Finance

ML Signal

N/A

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$15.29

Market Cap

562.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PRAA
VOR
Founded
1996
2015
Country
United States
United States
Employees
170
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
639.1M
562.6M
IPO Year
2002
2021

Fundamental Metrics

Financial Performance
Metric
PRAA
VOR
Price
$18.41
$15.29
Analyst Decision
Buy
Buy
Analyst Count
3
10
Target Price
$24.50
$64.78
AVG Volume (30 Days)
672.4K
618.2K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.86
EPS
N/A
N/A
Revenue
$1,201,837,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$2.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.83
N/A
52 Week Low
$10.25
$0.13
52 Week High
$22.01
$49.95

Technical Indicators

Market Signals
Indicator
PRAA
VOR
Relative Strength Index (RSI) 72.31 55.49
Support Level $13.16 $11.76
Resistance Level $19.83 $16.95
Average True Range (ATR) 1.03 1.13
MACD 0.90 0.04
Stochastic Oscillator 91.30 56.99

Price Performance

Historical Comparison
PRAA
VOR

About PRAA PRA Group Inc.

PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Share on Social Networks: